.svg){kind=small}
Adaptive Phase I & II Trials
View service.svg)
Phase III Clinical Studies
View service.svg)
TQT Studies
View service.svg)
Bridging Studies
View service.svg)
Patient Recruitment
View service.svg)
Data Management
View service
Adaptive Phase I & II Trials
View servicePhase III Clinical Studies
View serviceTQT Studies
View serviceBridging Studies
View servicePatient Recruitment
View serviceData Management
View service
.avif)
Latest news
Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy
September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
